Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan vs Placebo for Aortic Root Dilatation in Marfan Syndrome
NCT00782327Phase 3Completed
- Sponsor
- Ghent University Hospital
- Start
- Nov 2009
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of losartan in Marfan syndrome (MFS), sponsored by Ghent University Hospital. Primary endpoint: Rate of aortic root growth at the level of sinuses of Valsalva at 3 years. Started Nov 2009; status: completed.
02
Drugs
losartan
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on NCT00782327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782327.